Literature DB >> 16527273

Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells.

Christina B Fieber1, Juanita Eldridge, Tarek A Taha, Lina M Obeid, Robin C Muise-Helmericks.   

Abstract

Akt kinase is an important downstream effector of VEGF in primary endothelial cells (EC), promoting angiogenesis by increased cellular survival, motility and tubulogenesis. Akt1 is the founding member of a family of serine threonine kinases thought to have overlapping function. We sought to determine if other Akt family members were also regulated by VEGF in EC. We show that treatment of EC with the angiogenic inducers VEGF or sphingosine-1-phosphate (S1P) results in an increased stabilization of Akt3 mRNA, concurrent with a PI3 kinase-dependent, Akt1-independent increase in both the protein and its phosphorylation. Given the similarity of Akt3 regulation by VEGF and S1P, the sensitivity of VEGF stimulation to the Gi-protein uncoupling reagent, pertussis toxin was tested and shows that VEGF stimulation requires Gi-protein signaling. We show that the VEGF stimulates the expression of Edg3/S1P3 (S1P3) and that expression of this Gi-protein-coupled receptor is both sufficient and necessary for the expression of Akt3. Blockade of a single isoform does not overtly affect cellular function, whereas inhibition of both kinases results in an increase in apoptosis and a down-regulation of cyclin D3. These results suggest a model whereby extracellular cues maintain total Akt kinase levels through the regulation of specific isoform expression providing a fail-safe mechanism to maintain necessary levels of Akt kinase activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527273     DOI: 10.1016/j.yexcr.2006.01.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

Review 1.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.

Authors:  Tiera A Liby; Perry Spyropoulos; Haley Buff Lindner; Juanita Eldridge; Craig Beeson; Tien Hsu; Robin C Muise-Helmericks
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

3.  Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃.

Authors:  Elisabeth I Schmitz; Henrik Potteck; Melanie Schüppel; Marianti Manggau; Elly Wahydin; Burkhard Kleuser
Journal:  Mol Cell Biochem       Date:  2012-08-17       Impact factor: 3.396

4.  Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone.

Authors:  Domenico Raimondo; Cristina Remoli; Letizia Astrologo; Romina Burla; Mattia La Torre; Fiammetta Vernì; Enrico Tagliafico; Alessandro Corsi; Simona Del Giudice; Agnese Persichetti; Giuseppe Giannicola; Pamela G Robey; Mara Riminucci; Isabella Saggio
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

5.  Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.

Authors:  Giuditta Illuzzi; Caterina Bernacchioni; Massimo Aureli; Simona Prioni; Gianluca Frera; Chiara Donati; Manuela Valsecchi; Vanna Chigorno; Paola Bruni; Sandro Sonnino; Alessandro Prinetti
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

6.  Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.

Authors:  Malgorzata M Ptaszynska; Michael L Pendrak; Mary L Stracke; David D Roberts
Journal:  Mol Cancer Res       Date:  2010-03-02       Impact factor: 5.852

Review 7.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

8.  VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase.

Authors:  Gary L Wright; Ioanna G Maroulakou; Juanita Eldridge; Tiera L Liby; Vijayalakshmi Sridharan; Philip N Tsichlis; Robin C Muise-Helmericks
Journal:  FASEB J       Date:  2008-06-04       Impact factor: 5.191

9.  AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM-1.

Authors:  Daniel G Corum; Philip N Tsichlis; Robin C Muise-Helmericks
Journal:  FASEB J       Date:  2013-09-30       Impact factor: 5.191

10.  In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody.

Authors:  Greg L Harris; Michael B Creason; Greg B Brulte; Deron R Herr
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.